Building Multiple Platforms to Address Difficult-to-Treat Cancers

On the Road to 50 States, Derek Hennecke, Investor at Inceptor Bio, talks to Nigel about what attracted him to Inceptor Bio and the technologies which Inceptor Bio are currently focusing on.

Q: